NCT00788892 2018-01-12Trial of CPX-351 in Newly Diagnosed Elderly AML PatientsJazz PharmaceuticalsPhase 2 Completed126 enrolled 12 charts
NCT00143975 2010-08-12Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM)University of UlmPhase 2 Completed95 enrolled